Institutional Fund
Nan Fung Group Holdings Ltd
Kai Tak, Hong KongCIK 17825395 filings on record
Portfolio Value
$121.26M
Q1 2026
Holdings
24
Reported positions
New Buys
2
Opened this quarter
QoQ Change
+8.5%
from $111.73M
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Evommune Inc27.3%
- Maplight Therapeutics Inc16.3%
- Lb Pharmaceuticals Inc12.8%
- Oculis Holding AG7.7%
- Incyte Corp4.2%
- Beone Medicines Ltd3.9%
- Other27.9%
Portfolio Holdings
24 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Evommune Inc | 1.44M | $33.13M | 27.3% | 0 | Held |
| 2 | Maplight Therapeutics Inc | 971.3K | $19.75M | 16.3% | 0 | Held |
| 3 | Lb Pharmaceuticals Inc | 630.7K | $15.55M | 12.8% | +330.7K | Added |
| 4 | Oculis Holding AG | 350.7K | $9.33M | 7.7% | −164.0K | Reduced |
| 5 | Incyte Corp | 53.7K | $5.06M | 4.2% | −5.3K | Reduced |
| 6 | Beone Medicines Ltd | 15.7K | $4.67M | 3.9% | 0 | Held |
| 7 | Rhythm Pharmaceuticals Inc | 49.1K | $4.27M | 3.5% | 0 | Held |
| 8 | Celcuity Inc | 28.3K | $3.23M | 2.7% | +28.3K | New |
| 9 | Ascendis Pharma A/S | 13.6K | $3.11M | 2.6% | 0 | Held |
| 10 | Procore Technologies Inc | 53.3K | $3.04M | 2.5% | 0 | Held |
14 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio